Welcome to our dedicated page for Churchill Cap X SEC filings (Ticker: CCCX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Churchill Capital Corp X (CCCX) files with the U.S. Securities and Exchange Commission as a blank check company listed on Nasdaq. This SEC filings page allows investors to review the company’s regulatory documents, which are central to understanding its structure as a special purpose acquisition company and its proposed business combination with ColdQuanta, Inc. (Infleqtion).
Key filings for Churchill Capital Corp X include current reports on Form 8-K, which disclose material events. One such Form 8-K describes the Agreement and Plan of Merger and Reorganization among Churchill Capital Corp X, two merger subsidiaries, and ColdQuanta, Inc., and notes the confidential submission of a draft registration statement on Form S-4. Subsequent communications reference the filing of a joint Form S-4 that includes a preliminary proxy statement/prospectus for Churchill Capital Corp X shareholders.
Through this page, users can access the company’s registration statements, proxy materials related to the proposed transaction, and other Exchange Act reports. These documents outline the terms of the business combination, the securities to be issued, and the risk factors associated with the transaction and the combined company. They also provide details on Churchill Capital Corp X’s units, Class A ordinary shares, and warrants listed on Nasdaq.
Stock Titan enhances these filings with AI-powered summaries that explain complex sections in plain language, helping readers interpret items such as merger terms, forward-looking statements, and risk disclosures. As new filings are made available through EDGAR, they are reflected here so that investors can review the latest information on CCCX, the proposed Infleqtion merger, and any subsequent corporate actions.
Use this page to examine Churchill Capital Corp X’s 8-K reports, registration statements on Form S-4, and related proxy and prospectus materials, and to understand how the company’s SPAC structure and planned business combination are documented in its official SEC submissions.
Infleqtion, Inc. (formerly Churchill Capital Corp X) reported that Chief Revenue Officer Paul Lipman received multiple grants of stock options on February 13, 2026. These derivative awards include a grant for 555,844 stock options and several additional option grants at an exercise price of $0.00 per share.
According to the disclosure, the options were received in connection with merger transactions completed under a September 8, 2025 agreement, where legacy ColdQuanta, Inc. options were converted into Infleqtion options with the same terms and conditions. Some options are fully vested, while others vest in equal monthly installments beginning on February 17, 2026, contingent on continued service.
Hall Jason Dean reported acquisition or exercise transactions in this Form 4 filing.
Churchill Capital Corp X granted Chief Legal Officer Jason Dean Hall a stock option covering 262,722 shares of common stock. This is a compensatory award rather than an open-market purchase.
According to the award terms, one quarter of the option vests on November 10, 2026. The remaining portion vests in equal monthly installments of 1/48 of the total shares on the same day of each following month, conditioned on Hall’s continued service with the company through each vesting date.
Hart Ilan reported acquisition or exercise transactions in this Form 4 filing.
Churchill Capital Corp X reported that Chief Financial Officer Ilan Hart received a grant of stock options covering 420,355 shares. The options were awarded for no cash payment and vest over time, with one quarter vesting on October 27, 2026 and the remainder vesting in equal monthly installments thereafter, subject to continued service.
Infleqtion, Inc. (formerly Churchill Capital Corp X) Chief Technology Officer Pranav Gokhale reported equity awards received on February 13, 2026. He acquired 2,338,980 shares of common stock at a price of $0.00 per share, plus stock options covering an additional 559,367 shares. Some options are already vested, while others vest in equal monthly installments beginning on February 17, 2026, subject to continued service. Several of these awards reflect legacy ColdQuanta equity that was converted into Infleqtion stock and options in connection with the company’s merger transaction.
Infleqtion, Inc.’s Chief Executive Officer and director Matthew John Kinsella reported multiple equity awards dated February 13, 2026. He received a stock option for 5,950,380 shares and another option for 481,727 shares, both granted at an exercise price of $0.00 per share. Some of these options vest monthly, with a portion accelerated at the closing of prior mergers, and legacy ColdQuanta options were converted into Infleqtion options on the same terms. Kinsella also reported indirect acquisitions of common stock awards of 560,327, 34,740 and 101,882 shares, held through Kinsella Investment Holdings, LLC and two John R. Kinsella family trusts over which he has voting and investment power.
Churchill Capital Corp X/Cayman director David B. Singer filed an initial Form 3 reporting indirect holdings of the company’s common stock. The shares are held by several investment entities, including Maverick Long Fund, Maverick Fund II, Maverick Advisors Fund, Maverick Designated Investments Fund, Maverick Ventures Investment Fund, and Maverick Silicon Fund.
The filing notes that Singer may have a pecuniary interest in these securities through carried interest or management roles but disclaims beneficial ownership for regulatory purposes except to the extent of that pecuniary interest.
Churchill Capital Corp X/Cayman, which trades under the ticker INFQ, filed an initial insider ownership report for director Dawn Clawson Meyerriecks. This Form 3 filing lists her status as a director and does not report any stock transactions or changes in ownership.
Churchill Capital Corp X/Cayman director reports initial holdings through a Form 3 filing. Kristina M. Johnson is identified as a director of the company, and the filing serves as her initial statement of beneficial ownership without reporting any specific share transactions.
Churchill Capital Corp X/Cayman director James Eric Bjornholt filed an initial Form 3, which is a statement of his beneficial ownership in the company’s securities. The filing reports his status as a director but does not list any buy, sell, or other share transactions.
Churchill Capital Corp X/Cayman director Catherine P. Lego has filed a Form 3, which is an initial statement of beneficial ownership of the company’s securities. The insider data provided shows no reported purchases, sales, acquisitions, or dispositions of shares in this filing.